Key result
Bilateral thoracotomies and combination chemotherapy achieved a complete response with no evidence of disease at five years in a patient with metastatic alveolar soft-part sarcoma.
Why the study?
Does multimodality therapy including pulmonary resection and chemotherapy improve survival in patients with ASPS and pulmonary metastases?
Case Report (n=1)
Does multimodality therapy including pulmonary resection and chemotherapy improve survival in patients with ASPS and pulmonary metastases?
Multimodality therapy including pulmonary resection and combination chemotherapy can lead to long-term disease-free survival in patients with metastatic alveolar soft-part sarcoma.
May support multimodality therapy in select metastatic ASPS; leaves open survival benefit in prospective cohorts.
Alveolar soft-part sarcoma (ASPS) is an unusual tumor of soft tissues; it has invariably ended in death from disseminated disease, and the lung has been the most common site of metastasis. We present a patient with ASPS with bilateral pulmonary metastases who achieved a complete response after bilateral thoracotomies with removal of all gross disease and after combination chemotherapy including vincristine, actinomycin D, cyclophosphamide, and doxorubicin. The patient has now been followed for five years since the appearance of the metastases and has been off therapy for the past 34 months. He shows no evidence of disease. We suggest that multimodality therapy is a reasonable approach in patients with ASPS and pulmonary metastases and that such therapy has the potential for improving survival.
No takes yet. Share an insight, caveat, or question.
Baum et al. (1981) conducted a case report in Alveolar soft-part sarcoma (ASPS) with bilateral pulmonary metastases (n=1). Bilateral thoracotomies and combination chemotherapy (vincristine, actinomycin D, cyclophosphamide, and doxorubicin) was evaluated on Complete response and disease-free survival. Bilateral thoracotomies and combination chemotherapy achieved a complete response with no evidence of disease at five years in a patient with metastatic alveolar soft-part sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: